Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Proprietary name formulation

Proprietary blend formulations based on polysulfone, polyethersulfone, and polyphenylsulfone are sold commercially by Amoco Corporation to meet various end use requirements. The blends based on polysulfone are sold under the MINDEL trademark. A glass fiber-reinforced blend based on PES is offered under the trade name RADEL AG-360. This offers most of the performance characteristics of 30% glass fiber-reinforced polyethersulfone but at a lower cost. Two blend product lines are offered based on PPSF. These are designated as the RADEL R-4000 and R-7000 series of products. The former is a lower cost alternative to RADEL R PPSF homopolymer offering most of the performance attributes unique to PPSF. The R-7000 series of resins have been formulated for use in aircraft interiors for civil air transport. They exhibit a very high degree of resistance to flammabihty and smoke release. [Pg.469]

The monomers, eatalysts or hardeners, or plastieizers ean inelude ehemieals with the potential to irritate the skin, mueous membranes or respiratory traet. Some ean promote skin or respiratory sensitization. The range of ehemieals in use is extremely wide, so that referenee should be made to the Materials Safety Data Sheet for eaeh speeifie formulation or variation of it identifiable by referenee to the supplier s proprietary name and eode number. Some eommon resin types are summarized in Table 5.55. [Pg.144]

The first plot received 500 g.a.i./h of displarlure as NCR gelatin-walled microcapsules containing 2% ai. The formulation, applied as an aqueous suspension, also contained 1 of sticker to aid adhesion of the formulation to foliage. The second plot received 500 g./h. as Herculite Corporation sprayable laminate flakes containing 9.1 ai. The flakes consisted of two layers of vinyl, each 0.08 mm thick on both sides of a central porous layer containing the disparlure the surface area of the flakes was between 7 and 35 mm2 per side. The same sticker as that in the microcapsules was used. The third plot received 330 g.a.i./h as "Conrel" controlled release hollow fibers containing nominally 11.5% ai. a suitable sticker was also incorporated in the formulation. (Note that the use of trade or proprietary names here or elsewhere does not constitute an endorsement by the USDA). [Pg.194]

Proprietary Name Manufacturer Generic/ Concentration Formulation... [Pg.236]

The proprietary name is a trade mark applied to particular formulation(s) of a particular substance by a particular manufacturer. Manufacture is confined to the owner of the trade mark or to others licensed by the owner. It is designed to maximise the difference between the names of similar drugs marketed by rivals for obvious commercial reasons. To add confusion, some companies give their proprietary products the same names as their generic products in an attempt to capture the prescription market, both proprietary and generic, and some market lower-priced generics of their own proprietaries. When a prescription is written for a proprietary product, pharmacists under UK law must dispense that product only. But by agreement... [Pg.84]

It is reasonable to use proprietary names when dosage, and therefore pharmaceutical bioavadability, are critical so that small variations in the amoimt of drug available for absorption can have big effects on the patient, e.g. drugs with low therapeutic ratio, digoxin, hormone replacement therapy, adrenocortical steroids (oral), antiepileptics, cardiac anti-arrhythmics, warfarin. Also, with the introduction of complex formulations, e.g. sustained-release, it is important clearly to identify these, and use of proprietary names has a role. [Pg.85]

Change of proprietary name of medicine, transfer of applicancy, amendment of manufacturer/packer/testing laboratory, formulation change... [Pg.665]

Proprietary name for a pitch-like substance formulated for lining concrete vessels. [Pg.270]

Drugs are usually called by their recommended or proposed International Non-proprietary Names (rINN or pINN) when these are not available, chemical names have been used. If a fixed combination has a generic combination British Approved Name (e.g. co-trimoxazole for trimethoprim -I- sulfamethoxazole) that name has been used in some cases brand names have been used instead. When the plus symbol (-I-) is used to link drug names (for example, lopinavir -I- ritonavir ), it impUes that the two drugs are administered either in one formulation or in conjunction with one another otherwise the word plus is used. [Pg.886]

Proprietary Names (1) combined with acetaminophen (multiple different preparations in tablet, capsule, and elixir form) Vicodin , Lortab , Norco , and numerous generic formulations (2) combined with aspirin or ibuprofen Damason-P , Vicoprofen ... [Pg.112]

Whole premixed mud systems and individual mud ingredients were supplied by Rheochem Ltd., Henderson, Western Australia. Two whole drilling mud systems, Syndrill 80 20 and modified Syndrill 80 20 (Mod), were mixed in small individual batches by Rheochem. The composition of chemicals used in the formulation was regarded as proprietary or confidential information and is not disclosed in this publication. Seven potential alternative emulsifiers were utilized, namely Emul S50,... [Pg.315]

Although nickel is present in varying amounts in stainless steel commercially a high-nickel stainless steel is not categorized as a nickel alloy, but rather as a stainless steel. Most nickel alloys are proprietary formulations and hcncc designated by trade names, such as Duranickel. Monel (several), Haste Hoy (several). Waspahy, Rene 42, Inco, Inconel (several), and lllium G. The nickel content will range from about 30% to nearly 95%. [Pg.58]

Some of the closely related organic sulfides and thioacetals have found commercial pesticidal use. These formulations include Mikazin. Fluoroparacide. and Fluorosulfacide. Names are proprietary in most cases. [Pg.847]

Mixed insulin zinc suspension is, confusingly, the approved name for proprietary mixtures of crystalline and amorphous zinc suspension. Mixed insulins are not, therefore, the same as biphasic insulins. While the different proprietary formulations in this group do have differing time courses of action (see Fig. 35.1) depending on their (unstated) proportions of amorphous and crystalline suspension, it is not expected that doctors or patients would vary the formulation prescribed. [Pg.684]

Drugs that have similar names are not infrequently confused. The name of Sanofi-Synthelabo s brand of sodium polystyrene sulfonate, Kayexalate, could be confused with the names of proprietary brands of potassium chloride, such as Kay-Cee-L and Kay-Ciel. Furthermore, some formulations of potassium chloride are formulated in packaging that resembles that of Kayexalate. There have been two deaths when potassium chloride was given instead of sodium polystyrene sulfonate for hyperkalemia (31). [Pg.2896]

Identifying Information The label of a hazardous substance must state conspicuously the name and place of business of the manufacturer, packer, distributor or seller. In addition, it must disclose the identity of the heizardous substance or, where the substance is a mixture, the identity of each component which contributes substantially to the hazard. The statute embodies a clear preference for providing the common or usual name of the heizardous substance the substance s chemical name need only be provided if no common usual name exists. By regulation, the Commission may permit or require the use of a recognized generic name. Such a generic name would appear appropriate where a more detailed description would either confuse product users or disclose information about the product s formulation that the manufacturer considers proprietary. [Pg.331]

Many people have suggested that we use the actual brand names of products and list the hazards of the specific chemicals they contain. This would not be possible for several reasons. Many manufacturers consider their ingredients list to be proprietary information. That means they do not divulge the formulations. Another reason this would not be feasible is that manufacturers frequently change the formulations of products to save money, increase effectiveness, or improve the product in some way. [Pg.574]


See other pages where Proprietary name formulation is mentioned: [Pg.998]    [Pg.324]    [Pg.17]    [Pg.318]    [Pg.3]    [Pg.54]    [Pg.305]    [Pg.104]    [Pg.193]    [Pg.477]    [Pg.348]    [Pg.193]    [Pg.848]    [Pg.68]    [Pg.533]    [Pg.191]    [Pg.1891]    [Pg.281]    [Pg.314]    [Pg.379]    [Pg.103]    [Pg.398]    [Pg.27]    [Pg.348]    [Pg.728]   
See also in sourсe #XX -- [ Pg.5 , Pg.16 , Pg.84 ]




SEARCH



Proprietary

© 2024 chempedia.info